Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $1.87 Million - $2.16 Million
-7,800 Reduced 14.72%
45,200 $11.4 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $10.7 Million - $13.5 Million
45,200 Added 579.49%
53,000 $13.4 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $4.84 Million - $5.94 Million
-18,800 Reduced 70.68%
7,800 $2.29 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $5.72 Million - $6.45 Million
19,600 Added 280.0%
26,600 $8.75 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $1.91 Million - $2.33 Million
7,000 New
7,000 $2.13 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $3.44 Million - $4.16 Million
-15,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $2.12 Million - $2.46 Million
10,000 Added 188.68%
15,300 $3.44 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $765,000 - $883,656
3,600 Added 211.76%
5,300 $1.18 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $667,645 - $929,775
-5,500 Reduced 76.39%
1,700 $235,000
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $54,160 - $58,588
400 Added 5.88%
7,200 $1.04 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $474,544 - $546,174
3,800 Added 126.67%
6,800 $972,000
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $292,860 - $396,870
3,000 New
3,000 $396,000
Q4 2018

Feb 14, 2019

SELL
$94.85 - $109.54 $1.41 Million - $1.63 Million
-14,900 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $3.27 Million - $3.63 Million
-33,300 Reduced 69.09%
14,900 $1.62 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $1.46 Million - $1.57 Million
15,200 Added 46.06%
48,200 $4.76 Million
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $3.04 Million - $3.43 Million
33,000 New
33,000 $3.23 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.